Jundishapur Journal of Microbiology

Published by: Kowsar

Prevalence of Extended-Spectrum and Metallo β-Lactamase Production in AmpC β-Lactamase Producing Pseudomonas Aeruginosa Isolates From Burns

Roya Rafiee 1 , Fereshteh Eftekhar 1 , * , Seyyed Ahmad Tabatabaei 2 and Dariush Minaee Tehrani 1
Authors Information
1 Department of Microbiology, Faculty of Biological Sciences, Shahid Beheshti University, Tehran, IR Iran
2 Department of Pediatrics, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: September 01, 2014, 7 (9); e16436
  • Published Online: September 1, 2014
  • Article Type: Research Article
  • Revised: June 9, 2014
  • Accepted: June 21, 2014
  • DOI: 10.5812/jjm.16436

To Cite: Rafiee R, Eftekhar F, Tabatabaei S A, Minaee Tehrani D. Prevalence of Extended-Spectrum and Metallo β-Lactamase Production in AmpC β-Lactamase Producing Pseudomonas Aeruginosa Isolates From Burns, Jundishapur J Microbiol. 2014 ; 7(9):e16436. doi: 10.5812/jjm.16436.

Abstract
Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Fluit AC, Verhoef J, Schmitz FJ. Antimicrobial resistance in European isolates of Pseudomonas aeruginosa. European SENTRY Participants. Eur J Clin Microbiol Infect Dis. 2000; 19(5): 370-4[PubMed]
  • 2. Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 2009; 22(4): 582-610[DOI][PubMed]
  • 3. Selim S, El Alfy S, Al Ruwaili M, Abdo A, Al Jaouni S. Susceptibility of imipenem-resistant Pseudomonas aeruginosa to flavonoid glycosides of date palm (Phoenix dactylifera L.) tamar growing in Al Madinah, Saudi Arabia. Afr J Biotechnol. 2012; 11(2): 416-22
  • 4. Coetzee E, Rode H, Kahn D. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit. S Afr J Surg. 2013; 51(2): 50-3[DOI][PubMed]
  • 5. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis. 2002; 34(5): 634-40[DOI][PubMed]
  • 6. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995; 39(6): 1211-33[PubMed]
  • 7. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005; 18(4): 657-86[DOI][PubMed]
  • 8. Zhao WH, Hu ZQ. Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa. Crit Rev Microbiol. 2010; 36(3): 245-58[DOI][PubMed]
  • 9. Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev. 2009; 22(1): 161-82[DOI][PubMed]
  • 10. Weldhagen GF, Poirel L, Nordmann P. Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agents Chemother. 2003; 47(8): 2385-92[PubMed]
  • 11. Rodriguez-Martinez JM, Poirel L, Nordmann P. Extended-spectrum cephalosporinases in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2009; 53(5): 1766-71[DOI][PubMed]
  • 12. Salimi F, Eftekhar F. Coexistence of AmpC and extendedspectrum β-lactamases in metallo-β-lactamase producing Pseudomonas aeruginosa burn isolates in Tehran. Jundishapour J Microbiol. 2013; 6(8)
  • 13. Cockerill FR. Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement;[... provides updated tables for... M02-A11 and M07-A9]. 2012;
  • 14. Singhal S, Mathur T, Khan S, Upadhyay DJ, Chugh S, Gaind R, et al. Evaluation of methods for AmpC beta-lactamase in Gram negative clinical isolates from tertiary care hospitals. Indian J Med Microbiol. 2005; 23(2): 120-4[PubMed]
  • 15. Manchanda V, Singh NP. Occurrence and detection of AmpC beta-lactamases among Gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India. J Antimicrob Chemother. 2003; 51(2): 415-8[PubMed]
  • 16. Lin SP, Liu MF, Lin CF, Shi ZY. Phenotypic detection and polymerase chain reaction screening of extended-spectrum beta-lactamases produced by Pseudomonas aeruginosa isolates. J Microbiol Immunol Infect. 2012; 45(3): 200-7[DOI][PubMed]
  • 17. Upadhyay S, Sen MR, Bhattacharjee A. Presence of different beta-lactamase classes among clinical isolates of Pseudomonas aeruginosa expressing AmpC beta-lactamase enzyme. J Infect Dev Ctries. 2010; 4(4): 239-42[PubMed]
  • 18. Prevalence of plasmid-mediated AmpC β-lactamases in Klebsiella pneumoniae (KP), Klebsiella oxytoca (KO), Proteus mirabilis (PM), and Salmonella (S) isolates from 42 ICU and 21 non-ICU sites in the United States. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICCAC).
  • 19. Black JA, Moland ES, Thomson KS. AmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases. J Clin Microbiol. 2005; 43(7): 3110-3[DOI][PubMed]
  • 20. Basak S, Khodke M, Bose S, Mallick SK. Inducible Amp C beta-lactamase producing Pseudomonas aeruginosa isolated in a rural hospital of central India. J Clin Diagn Res. 2009; 3: 19-7
  • 21. Shahid M, Malik A, Agrawal M, Singhal S. Phenotypic detection of extended-spectrum and AmpC beta-lactamases by a new spot-inoculation method and modified three-dimensional extract test: comparison with the conventional three-dimensional extract test. J Antimicrob Chemother. 2004; 54(3): 684-7[DOI][PubMed]
  • 22. Kumar V, Sen MR, Nigam C, Gahlot R, Kumari S. Burden of different beta-lactamase classes among clinical isolates of AmpC-producing Pseudomonas aeruginosa in burn patients: A prospective study. Indian J Crit Care Med. 2012; 16(3): 136-40[DOI][PubMed]
  • 23. Sreeshma P, Champa H, Sunil RP, Subbannayya K. Detection of extended spectrum β-lactamase, AmpC β-lactamase and metallo β-lactamase in clinical isolates of Pseudomonas aeruginosa. J Pharm Biomed Sci. 2013; 33(33): 1506-15
  • 24. Fazeli H, Sadighian H, Esfahani BN, Pourmand MR. Identification of class-1 integron and various β-lactamase classes among clinical isolates of Pseudomonas aeruginosa at children's medical center hospital. J Med Bacteriol. 2012; 1(2): 25-36
  • 25. Laghawe A, Jaitly N, Thombare V. The Simultaneous Detection of the ESBL and the AmpC β-Lactamases in Gram Negative Bacilli. J Clin Diag Res. 2012; 6(4suppl2): 660-3
  • 26. Thomson KS. Controversies about extended-spectrum and AmpC beta-lactamases. Emerg Infect Dis. 2001; 7(2): 333-6[DOI][PubMed]
  • 27. Glupczynski Y, Bogaerts P, Deplano A, Berhin C, Huang TD, Van Eldere J, et al. Detection and characterization of class A extended-spectrum-beta-lactamase-producing Pseudomonas aeruginosa isolates in Belgian hospitals. J Antimicrob Chemother. 2010; 65(5): 866-71[DOI][PubMed]
  • 28. Imani Foloodi AA, Rostami Z, Shapouri R. Antimicrobial resistance and ESBL prevalence in Pseudomonas aeruginosa strains isolated from clinical specimen by phenotypic and genotypic methods. J Ardabil Univ Med Sci. 2010; 10(37): 189-98
  • 29. Jabalameli F, Mirsalehian A, Sotoudeh N, Jabalameli L, Aligholi M, Khoramian B, et al. Multiple-locus variable number of tandem repeats (VNTR) fingerprinting (MLVF) and antibacterial resistance profiles of extended spectrum beta lactamase (ESBL) producing Pseudomonas aeruginosa among burnt patients in Tehran. Burns. 2011; 37(7): 1202-7[DOI][PubMed]
  • 30. Shacheraghi F, Shakibaie MR, Noveiri H. Molecular Identification of ESBL genes blaGES-1, blaVEB-1, blaCTX-M blaOXA-1, blaOXA-4, blaOXA-10 and blaPER-1 in Pseudomonas aeruginosa strains isolated from burn patients by PCR, RFLP and sequencing techniques. Int J Biol life Sci. 2010; 3(6): 138-42
  • 31. Shahcheraghi F, Nikbin VS, Feizabadi MM. Prevalence of ESBLs genes among multidrug-resistant isolates of Pseudomonas aeruginosa isolated from patients in Tehran. Microb Drug Resist. 2009; 15(1): 37-9[DOI][PubMed]
  • 32. Zaranza AV, Morais FC, do Carmo MS, de Mendonça Marques A, Andrade-Monteiro C, Ferro TF, et al. Antimicrobial Susceptibility, Biofilm Production and Adhesion to HEp-2 Cells of Pseudomonas aeruginosa Strains Isolated from Clinical Samples. J Biomat Nanobiotechnol. 2013; 4(1): 98-106
  • 33. Bush K. Carbapenemases: Partners in crime. J Glob Antimicrob Res. 2013; 1(1): 7-16
  • 34. Livermore DM, Woodford N. Carbapenemases: a problem in waiting? Curr Opin Microbiol. 2000; 3(5): 489-95[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments